Comparison of 24 hour control with Timoptic® 0.5% and Timoptic-XE(TM) 0.5% in exfoliation and primary open-angle glaucoma

Acta Ophthalmologica Scandinavica

Volumn 77, Issue 5, 1999, Pages 541-543

  Konstas, Anastasios G P ^a,b   Mantziris, Dimitrios A ^a   Maltezos, Athanasios ^a   Cate, Elin A ^b   Stewart, William C ^b,c  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b University of South Carolina   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Exfoliation and primary open angle glaucoma; Intraocular pressure; Timolol maleate

Indexed keywords

TIMOLOL; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; EXFOLIATION SYNDROME; EYE IRRITATION; FEMALE; HOSPITALIZATION; HUMAN; INTRAOCULAR PRESSURE; KERATOPATHY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TEAR FLOW; VISUAL IMPAIRMENT;

EID: 0032854369     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1999.770511.x     Document Type: Article

References (14)

1. A multi-dose, double-masked, parallel, active-treatment-controlled, multi-clinic study of 0.5% Timoptic-XE and 0.5% Timoptic in patients with elevated intraocular pressure (IOP). Merck & Co., Inc. Internal Report (1995) DA-TIMXE10.
2. Book SA (1978): Essentials of Statistics, New York: McGraw Hill Book Company, 117-122, 205-215.
3. Dickstein K, Aarsland T (1996): Comparison of the effects of aqueous and gellan opthalmic timolol on peak exercise performance in middle-aged men. Am J Ophthalmol 121: 367-371.
4. Henkind P, Leitman M, Weitzman E (1973): The diurnal curve in man: new observations. Invest Ophthalmol Vis Sci 12: 705-707.
5. Katavisto M (1964): The diurnal variations of ocular tension in glaucoma. Acta Ophthalmologica (Copenh) 74: 115-120.
6. Kitzawa Y, Horie T (1975): Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am J Glaucoma 79: 557-566.
7. Konstas AGP, Mantziris DA, Cate EA, Stewart WC (1997a): Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. Arch Ophthalmol 115: 975-979.
8. Konstas AGP, Mantziris DA, Stewart WC (1997b): Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 115: 182-185.
9. Laurence J, Holder D, Vogel R, et al (1993): A double-masked, placebo-controlled evaluation of timolol in a gel vehicle. J Glaucoma 2: 177-182.
10. Newell FW, Krill AE (1964): Diurnal tonography in normal and glaucomatous eyes. Tr Am Ophth Soc 62: 349-374.
11. Shedden AH (1994): Timolol maleate in gel-forming solution: A novel formulation of timolol maleate. Chilbret Int J Ophthalmol 10: 32-36.
12. Shields MB (1987): Textbook of Glaucoma, 2nd ed. Baltimore: Williams & Wilkins, p. 370.
13. Stewart WC, Leland TM, Cate EA, Stewart JA (1998): Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure. J Glaucoma 7: 402-407.
14. Stewart WC (1997): Current and future glaucoma therapy. Ciba Clinical Symposium, p. 1-43.